423 related articles for article (PubMed ID: 25708557)
1. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
[TBL] [Abstract][Full Text] [Related]
2. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
3. Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis.
Hwang IC; Park SM; Shin D; Ahn HY; Rieken M; Shariat SF
Asian Pac J Cancer Prev; 2015; 16(2):595-600. PubMed ID: 25684493
[TBL] [Abstract][Full Text] [Related]
4. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
5. The use of metformin in patients with prostate cancer and the risk of death.
Bensimon L; Yin H; Suissa S; Pollak MN; Azoulay L
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2111-8. PubMed ID: 25017246
[TBL] [Abstract][Full Text] [Related]
6. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
7. Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies.
Yu H; Yin L; Jiang X; Sun X; Wu J; Tian H; Gao X; He X
PLoS One; 2014; 9(12):e116327. PubMed ID: 25545701
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies.
Cai H; Xu Z; Xu T; Yu B; Zou Q
Diabetes Metab Res Rev; 2015 May; 31(4):336-43. PubMed ID: 25066306
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.
Zhang F; Yang Y; Skrip L; Hu D; Wang Y; Wong C; Qiu J; Lei H
Acta Diabetol; 2012 Dec; 49 Suppl 1():S235-46. PubMed ID: 23124624
[TBL] [Abstract][Full Text] [Related]
10. Association between metformin use and risk of prostate cancer and its grade.
Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
[TBL] [Abstract][Full Text] [Related]
11. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
12. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
13. Metformin use and prostate cancer risk: A meta-analysis of cohort studies.
Feng Z; Zhou X; Liu N; Wang J; Chen X; Xu X
Medicine (Baltimore); 2019 Mar; 98(12):e14955. PubMed ID: 30896668
[TBL] [Abstract][Full Text] [Related]
14. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
Zhang H; Gao C; Fang L; Zhao HC; Yao SK
Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
[TBL] [Abstract][Full Text] [Related]
15. The effect of metformin on mortality following cancer among patients with diabetes.
Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
[TBL] [Abstract][Full Text] [Related]
16. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
17. Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
Raval AD; Thakker D; Vyas A; Salkini M; Madhavan S; Sambamoorthi U
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):110-21. PubMed ID: 25667109
[TBL] [Abstract][Full Text] [Related]
18. Metformin and prostate cancer mortality: a meta-analysis.
Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
[TBL] [Abstract][Full Text] [Related]
19. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
20. [New clinical data with metformin therapy in patients with diabetes mellitus].
Jermendy G
Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
